169 related articles for article (PubMed ID: 4403394)
1. [Cardiovascular agents. 9. Effects of 1-tert-butylamino-3-(O-tetrahydrofurfuryloxy) phenoxy)-2-propanol hydrochloride (Y-6124) on experimental arrhythmia in dogs].
Nakanishi M; Imamura H; Nakamura T
Nihon Yakurigaku Zasshi; 1972 Mar; 68(2):240-53. PubMed ID: 4403394
[No Abstract] [Full Text] [Related]
2. [Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395)].
Laubie M; Cheymol G; Mouillé P; Gilbert JC; Schmitt H
Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):323-33. PubMed ID: 4146788
[No Abstract] [Full Text] [Related]
3. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the anti-arrhythmic action and beta-blocking potency of LB 46 and (--)-propranolol.
Flórez J; Arconada JA
Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):199-207. PubMed ID: 4396347
[No Abstract] [Full Text] [Related]
5. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
Nayler WG; Tay J
J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
[No Abstract] [Full Text] [Related]
6. [Antiarrhythmic action of penbutolol].
Boissier JR; Coutte R; Bertin MC; Giudicelli JF
Therapie; 1974; 29(2):261-9. PubMed ID: 4152641
[No Abstract] [Full Text] [Related]
7. Comparison of the effects of various betaadrenergic blocking agents with known antiarrhythmic drugs on aconitine-arrhythmia produced by the cup method.
Nakayama K; Oshima T; Kumakura S; Hashimoto K
Eur J Pharmacol; 1971; 14(1):9-18. PubMed ID: 4396662
[No Abstract] [Full Text] [Related]
8. [Studies on cardiovascular drugs. 8. Metabolism of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
Nakanishi M; Kato Y; Arima N
Yakugaku Zasshi; 1972 Mar; 92(3):299-304. PubMed ID: 4403111
[No Abstract] [Full Text] [Related]
9. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
Nakanishi M; Imamura H; Nakamura T; Kimura T
Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
[No Abstract] [Full Text] [Related]
10. [Treatment of arrhythmias with practolol (Eraldin)].
Van Durme JP; Bossaert L; Vermeire P; Pannier R
G Ital Cardiol; 1972; 2(1):161-2. PubMed ID: 4401034
[No Abstract] [Full Text] [Related]
11. [Antiarrhythmic effect of butidrine: experimental study on arrhythmias induced by N-adrenaline in halothane anesthesia].
Rossano C; Romoli M; Brunozzi LT; Monti GB; Pavoni P
Acta Anaesthesiol; 1969; 20(4):663-700. PubMed ID: 4397385
[No Abstract] [Full Text] [Related]
12. [Effects of trimepranol and propranolol in thyreotoxicosis and in patients with arrhythmia].
Vána S; Felt V; Nĕmec J; Zamrazil V
Cas Lek Cesk; 1972 Jun; 111(20):454-9. PubMed ID: 4402995
[No Abstract] [Full Text] [Related]
13. [Use of pindolol (LB 46), a new beta-blockader in disorders of cardiac rhythm].
Poletti T; Aquaro G
Minerva Cardioangiol; 1972; 20(7):402-18. PubMed ID: 4403233
[No Abstract] [Full Text] [Related]
14. [Studies on cardiovascular drugs. XII. Pharmacological properties of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
Imamura H; Nakamura T; Inui J; Yasuda H; Osuga K
Yakugaku Zasshi; 1972 Aug; 92(8):1039-51. PubMed ID: 4404839
[No Abstract] [Full Text] [Related]
15. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT
J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
[No Abstract] [Full Text] [Related]
16. [Anti-arrythmic effects of DL-propranolol, D-propranolol and I.C.I.50 172 in experimental myocardial infarction in dogs].
Staszewska-Barczak J
Acta Physiol Pol; 1970; 21(3):317-29. PubMed ID: 4393011
[No Abstract] [Full Text] [Related]
17. [Studies on the influence of a beta-receptor blocking agent on plasma renin activity in man].
Distler A; Abdelhamid S; Philippi A; Rahn KH
Verh Dtsch Ges Inn Med; 1971; 77():937-9. PubMed ID: 4405363
[No Abstract] [Full Text] [Related]
18. [On the mechanism of the antiarrhythmic effect of beta-adrenergic receptor blocking drugs. Experimental research using 2 isomers of butidrin].
Mastandrea R; Malagnino G; Astorri E; Visoli O
Boll Soc Ital Cardiol; 1967; 12(5):525-8. PubMed ID: 5606898
[No Abstract] [Full Text] [Related]
19. Antiarrhythmic activity of bunolol, a new beta adrenergic blocking agent.
Kaplan HR; Robson RD
J Pharmacol Exp Ther; 1970 Oct; 175(1):168-77. PubMed ID: 4394302
[No Abstract] [Full Text] [Related]
20. A comparative study of dextro-alprenolol, dextro-propranolol, and practolol in treatment of ventricular ectopic beats.
Bennett D; Smith E; Sowton E
Br Heart J; 1970 Jul; 32(4):553. PubMed ID: 4393534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
